Genetic Study in Patients With Stage II or Stage III Colon Cancer
The Clinical and Pathological Significance of Allelic Imbalance of 8p in Patients With Colorectal Cancer
3 other identifiers
observational
598
2 countries
59
Brief Summary
RATIONALE: Genetic studies may help in understanding the genetic processes that cause some types of cancer. PURPOSE: Genetic trial to study certain genes of patients who have stage II or stage III colon cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 1999
Longer than P75 for all trials
59 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 1999
CompletedFirst Submitted
Initial submission to the registry
November 1, 1999
CompletedFirst Posted
Study publicly available on registry
January 27, 2003
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2006
CompletedJuly 13, 2016
July 1, 2016
7.5 years
November 1, 1999
July 12, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
overall survival
Up to 10 years
Study Arms (1)
Normal and tumor tissue pairs
Matched normal and tumor DNA is analyzed for 8p allelic imbalance with at least 8 markers: D8S262 and D8S1825 localized to 8p23, D8S254 and D8S261 at 8p22, D8S560 and D8S136 at 8p21, and D8S1820 and D8S283 at 8p12. Normal/tumor tissue pairs are used for fine mapping studies.
Interventions
Eligibility Criteria
Patients with advanced colon cancer previously participating in NCCTG-914653.
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
- Alliance for Clinical Trials in Oncologylead
- National Cancer Institute (NCI)collaborator
- NCIC Clinical Trials Groupcollaborator
Study Sites (59)
St. Mary's/Duluth Clinic Health System
Duluth, Minnesota, 55805, United States
Tom Baker Cancer Center - Calgary
Calgary, Alberta, T2N 4N2, Canada
Lethbridge Cancer Clinic
Lethbridge, Alberta, T1J 1W5, Canada
Nanaimo Cancer Clinic
Nanaimo, British Columbia, V9S 2B7, Canada
British Columbia Cancer Agency - Fraser Valley Cancer Centre
Surrey, British Columbia, V3V 1Z2, Canada
Prostate Centre at Vancouver General Hospital
Vancouver, British Columbia, V5Z 3J5, Canada
British Columbia Cancer Agency
Vancouver, British Columbia, V5Z 4E6, Canada
St. Paul's Hospital - Vancouver
Vancouver, British Columbia, V6Z 1Y6, Canada
G. Steinhoff Clinical Research
Victoria, British Columbia, V8V 3N1, Canada
Moncton Hospital
Moncton, New Brunswick, E1C 6ZB, Canada
Doctor Leon Richard Oncology Centre
Moncton, New Brunswick, E1C 8X3, Canada
Saint John Regional Hospital
Saint John, New Brunswick, E2L 4L2, Canada
Newfoundland Cancer Treatment and Research Foundation
St. John's, Newfoundland and Labrador, A1B 3V6, Canada
Nova Scotia Cancer Centre
Halifax, Nova Scotia, B3H 1V7, Canada
Cape Breton Cancer Centre
Sydney, Nova Scotia, B1P 1P3, Canada
Royal Victoria Hospital, Barrie
Barrie, Ontario, L4M 6M2, Canada
William Osler Health Centre
Brampton, Ontario, L6W 2Z8, Canada
Northeastern Ontario Regional Cancer Centre, Sudbury
Greater Sudbury, Ontario, P3E 5J1, Canada
Hamilton and District Urology Association
Hamilton, Ontario, L8N 1T8, Canada
London Health Sciences Centre
London, Ontario, N6A 4G5, Canada
Markham Stouffville Hospital
Markham, Ontario, L3P 7T3, Canada
Trillium Health Centre
Mississauga, Ontario, L5B 1B8, Canada
Credit Valley Hospital
Mississauga, Ontario, L5M 2N1, Canada
York County Hospital
Newmarket, Ontario, L3Y 2P9, Canada
North York General Hospital, Ontario
North York, Ontario, M2K 1E1, Canada
Male Health Centre/CMX Research Inc.
Oakville, Ontario, L6H 3PI, Canada
Lakeridge Health Oshawa
Oshawa, Ontario, L1G 2B9, Canada
Ottawa Regional Cancer Centre
Ottawa, Ontario, K1H 1C4, Canada
Peterborough Oncology Clinic
Peterborough, Ontario, K9H 7B6, Canada
Scarborough Hospital - General Site
Scarborough Village, Ontario, M1P 2V5, Canada
Hotel Dieu Health Sciences Hospital - Niagara
St. Catharines, Ontario, L2R 5K3, Canada
Northwestern Ontario Regional Cancer Centre, Thunder Bay
Thunder Bay, Ontario, P7A 7T1, Canada
Toronto East General Hospital
Toronto, Ontario, M4C 3E7, Canada
Toronto Sunnybrook Regional Cancer Centre
Toronto, Ontario, M4N 3M5, Canada
St. Michael's Hospital - Toronto
Toronto, Ontario, M5B 1W8, Canada
Mount Sinai Hospital - Toronto
Toronto, Ontario, M5G 1X5, Canada
Toronto General Hospital
Toronto, Ontario, M5G 2C4, Canada
Princess Margaret Hospital
Toronto, Ontario, M5G 2M9, Canada
Women's College Campus, Sunnybrook and Women's College Health Science Center
Toronto, Ontario, M5S 1B6, Canada
Saint Joseph's Health Centre - Toronto
Toronto, Ontario, M6R 1B5, Canada
Humber River Regional Hospital
Weston, Ontario, M9N 1N8, Canada
Cancer Care Ontario - Windsor Regional Cancer Centre
Windsor, Ontario, N8W 2X3, Canada
Queen Elizabeth Hospital, PEI
Charlottetown, Prince Edward Island, C1A 8T5, Canada
CHUS-Hopital Fleurimont
Fleurimont, Quebec, J1H 5N4, Canada
Hopital Charles Lemoyne
Greenfield Park, Quebec, J4V 2H1, Canada
Centre Hospitalier Regional de Lanaudiere
Joliette, Quebec, J6E 6J2, Canada
Centre Hospitalier de l'Universite de Montreal
Montreal, Quebec, (P.Q.) H2X 3J4, Canada
Maisonneuve-Rosemont Hospital
Montreal, Quebec, H1T 2M4, Canada
McGill University
Montreal, Quebec, H2W 1S6, Canada
Hopital Sainte Justine
Montreal, Quebec, H3T 1C5, Canada
Hopital Du Sacre-Coeur de Montreal
Montreal, Quebec, H4J 1C5, Canada
Kells Medical Research Group Inc.
Pointe-Claire, Quebec, H9R 4S3, Canada
Centre Hospitalier Universitaire de Quebec
Québec, Quebec, G1R 2J6, Canada
Hopital du Saint-Sacrament, Quebec
Québec, Quebec, G1S 4L8, Canada
Centre Hospitalier Regional de Rimouski
Rimouski, Quebec, G5L 5T1, Canada
L'Hopital Laval
Ste-Foy, Quebec, G1V 4G5, Canada
Allan Blair Cancer Centre
Regina, Saskatchewan, S4T 7T1, Canada
Saskatoon Cancer Centre
Saskatoon, Saskatchewan, S7N 4H4, Canada
Lions Gate Hospital
North Vancouver, V7L 2P9, Canada
Biospecimen
Normal and tumor tissue
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Richard M. Goldberg, MD
Mayo Clinic
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 1, 1999
First Posted
January 27, 2003
Study Start
February 1, 1999
Primary Completion
August 1, 2006
Study Completion
August 1, 2006
Last Updated
July 13, 2016
Record last verified: 2016-07